Cell and Gene Therapy On Track to Hit Record Number of Regulatory Approvals; Potential Implications for Commercial Real Estate Industry
While the CGT industry is growing at a rapid rate, real estate development happens much slower, which may have implications for the amount of available space.
Penn Spinout REGENXBIO Inc. Enters Commercial Phase; Focuses Gene Therapy on Common Cause of Blindness
Regenxbio's gene therapy would eliminate the need for wet AMD patients to visit their doctor every few months to receive a needle in their eye to treat their condition.
School of Dental Medicine and School of Engineering and Applied Science Develop Hands-Free System to Brush and Floss Teeth Using Microrobots
In a proof-of-concept study, microrobots effectively cleaned plaque and decay-causing bacteria from both mock and human teeth.
Penn Engineering Professor Linh Thi Xuan Phan Joins NSF Project on Cyber-Physical Systems for Transportation Technology
A major goal of this research is to help self-driving cars and other autonomous transportation systems achieve increased efficiency and performance, as well as better safety guarantees.
Three Penn Medicine Innovation Projects Receive Clinical Care Innovation Grants from Independence Blue Cross
Learn about these cutting-edge new projects that are improving value-based medical care.
Penn Medicine Ranks on List of Top US Health Systems by Merative and Fortune
Penn Medicine ranked number two out of the top five large health systems, second only to Mayo Clinic in Rochester, MN.
Carisma Therapeutics CEO Steve Kelly Wins Entrepeneur of the Year for Greater Philadelphia Region
Kelly is the CEO of Carisma Therapeutics, a PCI startup that provides cellular immunotherapy for solid tumors.
Marion Leary Speaks on her Innovation-Focused Nursing Career
Learn about Marion Leary and her mission to help health professionals pursue a career path in innovation.
PCI Fellows Program trains future commercialization leaders
PCI Fellows get exposure to a wide range of emerging technologies and commercialization opportunities in the life sciences, physical sciences, nanotechnology, and beyond.
Meet the 2022/2023 PCI Fellows Cohort
Twelve fellows were admitted to the 2022/2023 cohort out of a large application pool. We also have three returning Sr. fellows from last year.